It’s too soon to discard cotesting in cervical cancer

Dr. Spitzer is a professor of obstetrics and gynecology at Hofstra Northwell School of Medicine, Hempstead, N.Y., and a past president of the American Society for Colposcopy and Cervical Pathology. He reported receiving royalties from Elsevier, and consulting fees from Hologic, Biop Medical, Illumigen, and Merck.

References

1. Draft Recommendation Statement: Cervical Cancer: Screening. U.S. Preventive Services Task Force. September 2017.

2. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the U.S. Preventive Services Task Force. 2017.

3. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force. 2017.

4. J Natl Cancer Inst. 2014 Jul 18;106(8). pii: dju153.